Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Handler

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 18, 2016
New approaches to treating painAndrea Wolkerstorfer, Norbert Handler, Helmut Buschmann
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2023
The quality of drugs and drug products - Always guaranteed?Helmut Buschmann, Norbert Handler, Ulrike Holzgrabe
Archiv Der Pharmazie|December 15, 2005
Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazolesNorbert Handler, Walter Jaeger, Bea Kuen-Krismer, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2007
Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitorsNorbert Handler, Walter Jaeger, Helmut Puschacher, et al.
Arzneimittel-Forschung|April 3, 2008
Synthesis and biological activity of thienodiltiazem in isolated heart muscle preparations of guinea pigsNorbert Handler, Thomas Erker, Rosa Lemmens-Gruber, et al.
Bioorganic & Medicinal Chemistry|May 15, 2008
Benzanilides with spasmolytic activity: chemistry, pharmacology, and SARGerda Brunhofer, Norbert Handler, Klaus Leisser, et al.
Atherosclerosis|April 3, 2007
No evidence for modulation of endothelial nitric oxide synthase by the olive oil polyphenol hydroxytyrosol in human endothelial cellsChristoph A Schmitt, Norbert Handler, Elke H Heiss, et al.
Bioorganic & Medicinal Chemistry|July 3, 2007
'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitorsNorbert Handler, Gerda Brunhofer, Christian Studenik, et al.
Natural Product Communications|December 15, 2018
A Novel Genistein Prodrug: Design, Synthesis and Bioactivity on Mouse RAW264.7 MacrophagesBurkhard Kloesch, Silvia Loebsch, Jenny Breitenbach, et al.
Anticancer Research|February 7, 2016
Antiproliferative and Pro-apoptotic Activities of a Novel Resveratrol Prodrug Against Jurkat CD4+ T-CellsKatrin Goldhahn, Norbert Handler, Silvia Loebsch, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|January 18, 2016
New approaches to treating painAndrea Wolkerstorfer, Norbert Handler, Helmut Buschmann
Journal of Pharmaceutical and Biomedical Analysis|December 16, 2023
The quality of drugs and drug products - Always guaranteed?Helmut Buschmann, Norbert Handler, Ulrike Holzgrabe
Archiv Der Pharmazie|December 15, 2005
Cyclooxygenase-1 and cyclooxygenase-2 inhibition of novel 1,2-disubstituted imidazolesNorbert Handler, Walter Jaeger, Bea Kuen-Krismer, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2007
Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitorsNorbert Handler, Walter Jaeger, Helmut Puschacher, et al.
Arzneimittel-Forschung|April 3, 2008
Synthesis and biological activity of thienodiltiazem in isolated heart muscle preparations of guinea pigsNorbert Handler, Thomas Erker, Rosa Lemmens-Gruber, et al.
Bioorganic & Medicinal Chemistry|May 15, 2008
Benzanilides with spasmolytic activity: chemistry, pharmacology, and SARGerda Brunhofer, Norbert Handler, Klaus Leisser, et al.
Atherosclerosis|April 3, 2007
No evidence for modulation of endothelial nitric oxide synthase by the olive oil polyphenol hydroxytyrosol in human endothelial cellsChristoph A Schmitt, Norbert Handler, Elke H Heiss, et al.
Bioorganic & Medicinal Chemistry|July 3, 2007
'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitorsNorbert Handler, Gerda Brunhofer, Christian Studenik, et al.
Natural Product Communications|December 15, 2018
A Novel Genistein Prodrug: Design, Synthesis and Bioactivity on Mouse RAW264.7 MacrophagesBurkhard Kloesch, Silvia Loebsch, Jenny Breitenbach, et al.
Anticancer Research|February 7, 2016
Antiproliferative and Pro-apoptotic Activities of a Novel Resveratrol Prodrug Against Jurkat CD4+ T-CellsKatrin Goldhahn, Norbert Handler, Silvia Loebsch, et al.
Pageof 3